Clinical Trial Update: COVID-19: Salvage TOcilizumab as a Rescue Measure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating salvage tocilizumab as a rescue measure for COVID-19 completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Disease 2019

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Jarmo Oksi | Conditions: Covid19 | Phase 3 | Status: COMPLETED